These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Migraine--current understanding and treatment. Goadsby PJ; Lipton RB; Ferrari MD N Engl J Med; 2002 Jan; 346(4):257-70. PubMed ID: 11807151 [No Abstract] [Full Text] [Related]
6. Recognition and treatment of migraine patient in dental practice. Weinberg MA; Gopinathan G N Y State Dent J; 2009 Mar; 75(2):28-33. PubMed ID: 19418878 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of frovatriptan. Tfelt-Hansen P Headache; 2007 Jun; 47(6):934; discussion 934. PubMed ID: 17578554 [No Abstract] [Full Text] [Related]
11. [Frovatriptan. For treatment of acute migraine]. Taéron C Rev Infirm; 2010; (157):47-9. PubMed ID: 20198950 [No Abstract] [Full Text] [Related]
12. Comparison of rizatriptan and sumatriptan. O'Quinn S; Mansbach H; Salonen R Headache; 1999 Jan; 39(1):59-60. PubMed ID: 18567177 [No Abstract] [Full Text] [Related]
13. Pharmacological treatment of migraine attack: a review of the literature. Antonaci F; Pucci E; Lanfranchi S; Sandrini G Rom J Neurol Psychiatry; 1994; 32(1):9-20. PubMed ID: 8038101 [No Abstract] [Full Text] [Related]
14. The scientific basis of migraine. Wynn DR Postgrad Med; 2000 Sep; 108(3 Suppl):4-9. PubMed ID: 19667524 [TBL] [Abstract][Full Text] [Related]
15. The discovery and development of the triptans, a major therapeutic breakthrough. Humphrey PP Headache; 2008 May; 48(5):685-7. PubMed ID: 18471110 [TBL] [Abstract][Full Text] [Related]
16. [Causes, pathophysiology and therapy of migraine]. Christiani K Krankenpfl J; 1981 Mar; 19(3):13-5. PubMed ID: 6909427 [No Abstract] [Full Text] [Related]
17. Frovatriptan and data publication. Tfelt-Hansen P Headache; 2008 Oct; 48(9):1382-3. PubMed ID: 19006553 [No Abstract] [Full Text] [Related]
18. [Utilizing the strength(s) of rizatriptan 10 mg: cost effective against migraine attacks]. MMW Fortschr Med; 2009 Mar; 151(13):92-3. PubMed ID: 19504831 [No Abstract] [Full Text] [Related]
19. [Bonus-malus regulations in the framework of the AVWG guideline-suitable migraine therapy are possible]. MMW Fortschr Med; 2007 May; 149 Suppl 2():102-3. PubMed ID: 17724980 [No Abstract] [Full Text] [Related]